Cargando…
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
Despite the leaps and bounds in achieving success in the management and treatment of breast cancers through surgery, chemotherapy, and radiotherapy, breast cancer remains the most frequently occurring cancer in women and the most common cause of cancer-related deaths among women. Systemic therapeuti...
Autores principales: | Samuel, Samson Mathews, Varghese, Elizabeth, Koklesová, Lenka, Líšková, Alena, Kubatka, Peter, Büsselberg, Dietrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565921/ https://www.ncbi.nlm.nih.gov/pubmed/32883003 http://dx.doi.org/10.3390/cancers12092482 |
Ejemplares similares
-
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
por: Varghese, Elizabeth, et al.
Publicado: (2021) -
Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
por: Varghese, Elizabeth, et al.
Publicado: (2020) -
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
por: Varghese, Elizabeth, et al.
Publicado: (2020) -
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
por: Samuel, Samson Mathews, et al.
Publicado: (2019) -
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
por: Varghese, Sharon, et al.
Publicado: (2019)